Relating structure to function: The role of the C2 domain in Factor VIII

Current Opinion in Drug Discovery and Development

Volumn 3, Issue 5, 2000, Pages 516-526

  Pratt, K P ^a  

^a USA   (United States)

Author keywords

Coagulation; Crystal structure; Factor VIII; Hemophilia A; Membrane binding

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; BLOOD CLOTTING FACTOR 9A; CALCIUM ION; THROMBIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; BINDING SITE; BLOOD CLOTTING; CRYSTAL STRUCTURE; HEMOPHILIA A; HEMOSTASIS; HUMAN; MEMBRANE BINDING; MOLECULAR INTERACTION; NONHUMAN; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 0033774746     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. The life cycle of coagulation Factor VIII in view of its structure and function
2. Regulation of factor VIIIa in the intrinsic factor Xase
3. Blood coagulation Factors V and VIII: Structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders
4. Biochemistry and physiology of blood coagulation
5. Activation of porcine factor VIII:C by thrombin and Factor Xa
6. Proteolytic processing of human Factor VIII. Correlation of specific cleavages by thrombin, Factor Xa, and activated protein C with activation and inactivation of Factor VIII coagulant activity
7. The effect of von Willebrand factor on activation of Factor VIII by Factor Xa
8. An arginine to cysteine amino acid substitution at a critical thrombin cleavage site in a dysfunctional Factor VIII molecule
9. Abnormal Factor VIII Hiroshima: Defect in crucial proteolytic cleavage by thrombin at Arg1689 detected by a novel ELISA
10. Purification of Factor VIII:C and Its characterization by western blotting using monoclonal antibodies
11. Binding of Factor VIIIa and Factor VIII to Factor IXa on phospholipid vesicles
12. The active site of Factor IXa is located far above the membrane surface and its conformation is altered upon association with Factor VIIIa
13. The role of phospholipid and Factor VIIIa in the activation of bovine Factor X
14. The A2 subunit of Factor VIIIa modulates the active site of Factor IXa
15. Liver transplantation in hemophilia A
16. Expression of active Factor Viii from recombinant DNA clones
17. Molecular cloning of a cDNA encoding human anti-haemophilic factor
18. Structure of human Factor VIII
19. Biosynthesis, assembly, and secretion of coagulation Factor VIII
20. Monoclonal antibodies to porcine Factor VIII coagulant and their use in the isolation of active coagulant protein
21. The size of human Factor VIII heterodimers and the effects produced by thrombin
22. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human Factor VIIIa
23. Inactivation of human Factor VIII by activated protein C: Cofactor activity of protein S and protective effect of von Willebrand factor
24. Identification of a binding site for blood coagulation Factor IXa on the light chain of human factor VIII
25. The affinity and stoichiometry of binding of human Factor VIII to von Willebrand factor
26. Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain
27. Human von Willebrand factor: A multivalent protein composed of identical subunits
28. A major Factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor
29. A mechanism for inhibition of Factor VIII binding to phospholipid by von Willebrand factor
30. Involvement of thrombin anion-binding exosites 1 and 2 in the activation of Factor V and Factor VIII
31. Specificity of phosphatidylserine-containing membrane binding sites for Factor VIII
32. The effect of plasma von Willebrand factor on the binding of human Factor VIII to thrombin-activated platelets
33. Structural and functional characterization of platalet receptor-mediated Factor VIII binding
34. A role for the C2 domain of Factor VIII in binding to von Willebrand factor
35. Slowed release of thrombin-cleaved Factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for Factor VIII inhibition
36. Activation of Factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets
37. The effect of thrombin on the complex between Factor VIII and von Willebrand factor
38. Association of the Factor VIII light chain with von Willebrand factor
39. Proteolytic requirements for thrombin activation of anti-haemophilic factor (FVIII)
40. Differential proteolytic activation of Factor VIII-von Willebrand factor complex by thrombin
41. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human Factor VIII
42. Identification and functional requirement of Cu(I) and its ligands within coagulation Factor VIII
43. Human Factor VIIIa subunit structure
44. Thrombin-activated and human Factor Xa-activated human Factor VIII: Differences in cofactor activity and decay rate
45. The Factor VIII C2 domain contains the thrombin binding site responsible for thrombin-catalyzed cleavage at Arg 1689
46. Synthetic Factor VIII peptides with amino acid sequences contained within the C2 domain of Factor VIII inhibit Factor VIII binding to phosphstidylserine
47. A Factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit Factor VIII binding to von Wilebrand factor and to phosphatidylserine
48. Localization of a Factor X interactive site in the A1 subunit of Factor VIIIa
49. Role of Factor VIII C2 domain in Factor VIII binding to Factor Xa
50. Specific membrane binding of factor VIII is mediated by O-phospho-L-sarine, a moiety of phosphatidylserine
51. Phosphatidylethanolamine induces high affinity binding sites for Factor VIII on membranes containing phosphatidyl-L-serine
52. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for Factor VIII
53. Activation of the Factor VIIIa-Factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl-L-serine
54. The role of phospholipids and Factor Va in the prothrombinase complex
55. The association of coagulation Factor Xa and Factor Va
56. The phospholipid binding property of the C2 domain of human Factor VIII
57. 35S-labeled recombinant Factor VIII to activated and unactivated human platelets
58. The role of platelet von Willebrand factor in the binding of Factor VIII to activated platelets
59. The physical exchange of Factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding
60. Membrane-binding peptide from the C2 domain of Factor VIII forms an amphipathic structure as determined by NMR spectroscopy
61. Comparison of activated protein C/protein S-mediated inactivation of human Factor VIII and Factor V
62. 2+ concentration, heparin, and activated protein C-catalyzed proteolysis
63. Model for the Factor VIIIa-dependent decay of the intrinsic factor Xase
64. The light chain of Factor VIII comprises a binding site for low-density lipoprotein receptor-related protein
65. Structure of the C2 domain of human Factor VIII at 1.5 Å resolution
66. Crystal structures of the membrane-binding C2 domain of human coagulation factor V
67. Identification of functionally important, amino acid residues within the C2 domain of human Factor V using alanine-scanning mutagenesis
68. Mutations In a potential phospholipid binding loop in the C2 domain of Factor V affecting the assembly of the prothrombinase complex
69. Proposed structure of the A domains of Factor VIII by homology modelling
70. A molecular model or the triplicated A domains of human Factor VIII based on the crystal structure of human ceruloplasmin
71. A domain mutations in 85 haemophilia A families and molecular modeling of dysfunctional Factor VIII proteins
72. Molecular models for the two discoidin domains of human blood coagulation Factor V
73. Homology models of the C domains of blood coagulation Factors V and VIII: A proposed membrane-binding mode for FV and FVIII C2 domains
74. Hemophilic Factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5 human C2-domain Å crystal structure
75. Electron crystallography of human blood coagulation Factor VIII bound to phospholipid monolayers
76. Structure of membrane-bound human Factor Va
77. X-ray structure of clotting Factor IXa: Active site and module structure related to Xase activity and hemophilla B
78. Factor VIII-Factor IX interactions: Molecular sites involved in enzyme-cofactor complex assembly
79. Haemophilia A: Database of nucleotide substitutions, deletions, insertions and rearrangements of the Factor VIII gene, second edition
80. Some Factor VIII (FVIII) inhibitors recognize a FVIII epitope(s) that is present only on FVIII-vWF complexes
81. The inhibitor antibody response is more complex in hemophilia A patients then in most non-hemophillacs with Factor VIII autoantibodies
82. Residues Giu2181-VaI2243 contain a major determinant of the inhibitory epitope in the C2 domain of human Factor VIII
83. Mechanism and kinetics of Factor VIII inactivation: Study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor
84. Factor VIII inhibitors In mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation
85. Identification of a Factor VIII peptide, residues 2315-2330, which neutralizes human Factor VIII C2 inhibitor alloantibodies: Requirement of Cys 2328 and Glu 2327 for maximum effect
86. Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: Factor VIII inhibitor antibodies from haemophilia A patients
87. Inhibitors in German hemophilia A patients treated with a double virus Inactivated Factor VIII concentrate bind to the C2 domain of FVIII light chain
88. Structural basis for haemophilia A caused by mutations in the C domains of blood coagulation Factor VIII
89. Human antibodies with specificity for the C2 domain of Factor VIII are derived from VH1 germline genes
90. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
91. A fast algorithm for rendering space-filling molecule pictures
92. Raster 3D version 2.0 - A program for photorealistic molecular graphics